An Observational Study Comparing Multiple Sclerosis International Quality of Life Questionnaire (MusiQoL) and Multiple Sclerosis Quality of Life-54 Instrument (MSQOL-54) in Relapsing Multiple Sclerosis (RMS) Patients on Long-term Rebif® Therapy
Clinical trial NCT01141751 · COMPLETED
Trial details
- NCT number
- NCT01141751
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2005-09-01
- Primary completion
- 2011-06-01
- Enrollment
- 334
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.